S. 1956 · 118th Congress

Invent Here, Make Here Act of 2024

Introduced on Jun 13, 2023 by Tammy Baldwin (D-WI). One cosponsor. Latest action (Dec 4, 2024): Held at the desk.

Stage
Passed one chamber
Introduced
Jun 13, 2023
Cosponsors
1
1 from the other party
Policy area
Commerce

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to improve the commercialization of Federal research by domestic manufacturers, and for other purposes.

Subjects

  • Advanced technology and technological innovations
  • Business investment and capital
  • Buy American requirements
  • Economic development
  • Manufacturing
  • Public-private cooperation
  • Research and development

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Tammy BaldwinD-WISponsor

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jun 13, 2023Introduced in Senate
  2. Jun 13, 2023 · SenateRead twice and referred to the Committee on Commerce, Science, and Transportation.
  3. Jul 31, 2024 · SenateCommittee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Aug 1, 2024Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
  5. Aug 1, 2024 · SenateCommittee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
  6. Aug 1, 2024 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 475.
  7. Dec 3, 2024Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
  8. Dec 3, 2024 · SenatePassed Senate with an amendment by Unanimous Consent. (consideration: CR S6787-6788; text: CR S6787-6788)
  9. Dec 4, 2024 · SenateMessage on Senate action sent to the House.
  10. Dec 4, 2024 · HouseReceived in the House.
  11. Dec 4, 2024 · HouseHeld at the desk.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. Association of American Universities6 reports
    $389.6K reported (all issues)
  2. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA4 reports
    $21.4M reported (all issues)
  3. INTEL CORPORATION3 reports
    $4.7M reported (all issues)Federal contractor: INTEL CORPORATIONAI match · 99%
  4. University of Michigan3 reports
    $190K reported (all issues)Federal contractor: UNIVERSITY OF MICHIGANAI match · 100%
  5. AMGEN INC.2 reports
    $5.6M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  6. BIOTECHNOLOGY INNOVATION ORGANIZATION2 reports
    $3.5M reported (all issues)
  7. GSK (fka GLAXOSMITHKLINE INC.)2 reports
    $2.5M reported (all issues)
  8. NATIONAL ASSOCIATION OF MANUFACTURERS2 reports
    $3.3M reported (all issues)
  9. Vanderbilt University2 reports
    $90K reported (all issues)Federal contractor: VANDERBILT UNIVERSITY$1.6M in contracts, FY2026AI match · 100%
  10. CTIA - THE WIRELESS ASSOCIATION1 report
  11. The University of Texas System1 report
    $130K reported (all issues)Federal contractor: UNIVERSITY OF TEXAS SYSTEM, THEAI match · 100%

Reports filed in 2023, 2024, 2025.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.